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Abstract  
Background 
Outcomes of diabetes care are unequal and the NHS has a duty to consider reducing inequality in 
healthcare outcomes. 
Aim 
To quantify trends in socioeconomic inequality in diabetes outcomes. 
Design and Setting 
Whole-population longitudinal study of 32,482 neighbourhoods (Lower Layer Super Output Areas) in 
England between 2004/5 and 2011/12. 
Method 
Slope indices of inequality between more and less deprived neighbourhoods measured annually for: 
(i) glycated haemoglobin control in diabetics, (ii) emergency hospitalisation for diabetes and (iii) 
mortality from diabetes.  
Results  
Between 2004/5 to 2011/12 glycaemic control improved in all social groups, although inequality was 
unchanged as measured by the SII (0.04, 95% CI -0.43 to 0.52). Diabetes mortality improved in all 
social groups, with faster mortality declines in more deprived neighbourhoods. Inequality in diabetes 
mortality improved, with the SII falling by 2.68 (95% CI 1.93 to 3.43) resulting in 594 (95% CI 420 to 
767) fewer deaths. In contrast emergency hospitalisations for diabetes increased in all social groups, 
with faster growth in more deprived neighbourhoods. The socioeconomic gradient increased with 
the SII widening by 19.59 admissions for diabetes per 100,000 (95% CI 16.00 to 23.17) resulting in an 
increase in excess admissions associated with socioeconomic inequality of 5,991 (95% CI 5,084 to 
6,899) compared to 2004/5. 
Conclusion 
In diabetes mortality declined faster, but emergency hospitalisation grew faster in more deprived 
neighbourhoods. Unequal growth in hospitalisation for diabetes is partly due to increased diabetes 
prevalence and patients living longer, but may also be due to over-use of glycaemic control 
medication. 
Keywords 
Diabetes mellitus, socioeconomic factors, quality of healthcare, mortality, emergency medicine, 
patient admission. 
 
How this fits in  
More than 2.7 million adults in the UK had a diagnosis of diabetes in 2013, 90% of which is type II 
diabetes. 
Type II diabetes is socially patterned with prevalence 50% higher in the most deprived fifth of the 
population compared with the least deprived fifth.  
Our research found that mortality from diabetes improved faster in more deprived neighbourhoods 
between 2004/5 and 2011/12, inequalities in glycaemic control were unchanged, while inequalities 
in emergency hospitalisations for diabetes complications increased faster.  
 
 
 
 
  
 
 
 
 
 
 
 
 
Introduction 
In 2013, 2.7 million adults over the age of 17 were diagnosed with diabetes in the UK.[1] 10% had 
type I diabetes [2] and 90% had type II diabetes, which is more likely to be influenced by lifestyle 
factors.[3] Type II diabetes is socially patterned, with prevalence approximately 50% higher in the 
most deprived compared with the least deprived quintile group.[4] Both types of diabetes have 
potentially serious complications decreasing both quality and length of life.[3] The NHS in England 
spent £3.9 million on diabetes services in 2009-10, approximately 4% of the NHS budget. [5] One 
important aspect of diabetes management is the control of HbA1c (glycated haemoglobin) levels, 
which reduces the risk of complications, hospitalisation and mortality. [6]  
In 2003, the UK Government made reducing health inequality a key priority of national health policy. 
[7, 8]  This was supported by several major investments with potential impact on reducing 
inequalities. Firstly, the Quality and Outcomes Framework (QOF) pay-for-performance programme 
introduced in 2004.[9] The QOF contains financial incentives for achieving clinical targets in 
controlling glycaemia, cholesterol levels, and blood pressure; and also for the recording of retinal 
screening, foot examination, neuropathy testing, and urine examination for microalbuminuria. 
Secondly, the ‘Equitable Access to Primary Care’ programme rolled out in 2008 invested £250 million 
in the 25% most under doctored primary care trusts (PCTs), providing over 100 new general 
practices and an additional GP-led health centre in each PCT.[10, 11] Thirdly, targeted support for 
effective primary care interventions for chronic conditions (including diabetes) in disadvantaged 
adults from 2007 to 2009.[12] In 2012, the NHS Health and Social Care Act gave the NHS an explicit 
duty to consider reducing  inequalities in healthcare outcomes.[13] In this study we examine NHS 
equity performance in tackling inequalities in diabetes outcomes during this key period. 
 
Methods  
We identified three indicators to track socioeconomic inequality in the outcomes of care for 
diabetes along the patient pathway. These indicators were developed using an iterative process 
involving the public, public health experts and NHS experts including those from primary and 
secondary care. [8]  
The first indicator was the achievement of good glycaemic control in patients with diabetes using the 
lower threshold target for HbA1c from QOF. We compared the number of people achieving this 
threshold with the number of people registered as having diabetes at GP practice level. The 
threshold has changed on various occasions since the inception of QOF in 2004/5 as detailed in Table 
1 and we used the relevant threshold for each period. 
The second indicator was preventable emergency hospitalisation for diabetes. We counted the 
number of people per 100,000 population having one or more emergency hospitalisations for those 
diabetes complications that are defined as being preventable by the NHS outcomes framework. [14] 
The ICD-codes for these complications are listed in Table 2. 
The final indicator was amenable mortality from diabetes related causes. This was defined as the 
number of deaths in a given year  per 100,000 population under the age of 75 from diabetes related 
causes considered amenable to health care by the ONS (primary cause of death ICD-10 codes E10 to 
E14).[15]  
For glycaemic control, we started with QOF achievement data which was available at GP practice-
level. We then used the ‘NHS Attribution Data Set’ of GP-registered populations to attribute 
glycaemic control data from practice to neighbourhood level using lower layer super output areas 
(LSOAs). Where LSOAs were attributed to more than one practice a population weighted average of 
glycaemic control scores from the relevant practices were used, assuming that the same level of 
glycaemic control was achieved across all practice patients independent of their LSOA of residence. 
There are 32,482 LSOAs in England each consisting of approximately 1,500 people (minimum 1,000, 
maximum 3,000). The index of multiple deprivation (IMD 2010) overall rank was used to assign 
deprivation ranks to LSOAs. Each indicator was calculated at LSOA level for each period between 
2004/5 and 2011/12 inclusive with each period running from the beginning of April to the end of 
March the following year. 
For the emergency hospitalisation outcome we used the Hospital Episodes Statistics (HES) dataset 
provided by the Health and Social Care Information Centre (HSCIC). For the amenable mortality 
outcome we used the Office of National Statistics (ONS) mortality dataset. These outcomes are 
available at LSOA-level and were indirectly standardised for age and sex at small area level. 
We measured absolute and relative inequality in these indicators using the slope index of inequality 
(SII) and relative index of inequality (RII) respectively. The SII was computed for each year by 
estimating an ordinary least squares regression of the LSOA level indicator value against the LSOA 
level deprivation fractional rank (measured on a 0-1 scale where 0 is the least deprived 
neighbourhood and 1 is the most deprived). The RII was calculated by expressing the SII as a 
proportion of the national mean level of the indicator. The SII can be interpreted as the modelled 
difference in event count between the least deprived and most deprived LSOAs in the country, 
taking into account the distribution of event counts across the deprivation range.  The RII can be 
interpreted as the proportional gap between the most and least deprived areas. For emergency 
hospitalisation and amenable mortality, where “more is worse”, a positive association implies “pro-
rich” inequality whilst a negative association implies “pro-poor” inequality. To ease comparison with 
the glycaemic control indicator, where “more is better”, we multiplied the SII by minus one, so that a 
positive sign also indicates “pro-rich” inequality. The area under the SII line was used to estimate the 
excess number of people experiencing the outcome measured by the indicator associated with 
socio-economic inequality – the “real inequality gap”. The assumption being that the level of the 
outcome observed in the least deprived area was the optimal level of the outcome and anything 
above this level for bad outcomes and below this level for good outcomes represented the excess 
associated with socio-economic inequality. 
Linear regression models were computed using pooled data for the first and last years, including 
interaction terms between year and deprivation, to determine the magnitude and statistical 
significance of changes in inequality between the beginning and end of the analysis period. All 
statistical analysis was carried out using R (version 3.2.3). 
 
Results  
In 2004/5 there were substantial socioeconomic gradients in both mortality and preventable 
hospitalisation for diabetes, and a smaller socioeconomic gradient in glycaemic control, with 
outcomes less favourable in more deprived neighbourhoods (figure 1). Figure 2 displays the trends 
from 2004/5 to 2011/12 comparing the most deprived (Q1) and least deprived (Q5) quintile groups 
of small areas in England. By 2011/12 substantial inequalities still remained and were associated 
with a deficit of 1.90 (95% CI 1.74 to 2.06) percentage points in diabetes related primary care quality 
(table 3), 22,189 (95% CI 21,498 to 22,881) excess preventable hospitalisations for diabetes related 
causes and 582 (95% CI 478 to 687) excess avoidable deaths due to diabetes related causes.  
Glycaemic control (table 3) 
In 2004/5 mean glycaemic control performance in England was 58.64% (95% CI 58.63 to 68.64). The 
SII was 3.76 (95% CI 3.40 to 4.11) indicating that the most deprived patients are nearly four 
percentage points less likely to achieve good glycaemic control than the least deprived patients. 
Between 2004/5 to 2011/12 there was an improvement in mean glycaemic control performance of 
3.72 percentage points (95% CI 3.72 to 3.72). However, inequality in glycaemic control was 
unchanged over the period according to both absolute and relative indices of inequality (SII 
difference 0.04, 95% CI -0.43 to 0.52). There was an improvement in primary care quality in between 
2010/11 and 2011/12 which may be the result of change in the HbA1C target from <7 to <7.5 that 
year. This also may have reduced hospitalisation (especially hypoglycaemia) due to less intensive 
treatment.   
Emergency hospitalisation (Table 3 and appendix 1) 
In 2004/5 the mean rate of preventable hospitalisation for diabetes was 59.84 (95% CI: 59.83 to 
59.85) admissions per 100,000 population. The SII was 64.66 (95% CI: 62.22 to 67.11) and 
socioeconomic inequality was associated with an excess of 16,199 (95% CI: 15,587 to 16,810) 
admissions. Between 2004/5 and 2011/12 admissions increased by 11.4 (95% CI 11.38 to 11.41) per 
100,000 population. The socioeconomic gradient also widened in both absolute and relative terms, 
with the SII widening by 19.59 admissions for diabetes per 100,000 (95% CI 16.00 to 23.17) resulting 
in an increase in excess admissions associated with socioeconomic inequality of 5,991 (95% CI 5,084 
to 6,899) compared to 2004/5. There was a fall in admissions between 2010/11 and 2011/12 which 
may be the result of change in the HbA1C target from <7 to <7.5 that year leading to less 
hypoglycaemia. 
The largest increases in numbers of  admissions were for unspecified hypoglycaemia (from 7476 to 
11564), type 2 diabetes without complications (from 6662 to 8401), type 1 diabetes with 
ketoacidosis without coma (from 6271 to 8841) and type 2 diabetes with ketoacidosis (from 1342 to 
2278).  
Diabetes mortality (Table 3 and appendix 2) 
In 2004/5 the mean rate of mortality from diabetes-related causes was 3.62 (95% CI 3.57 to 3.67) 
deaths per 100,000 population. The SII was 5.10 (95% CI 4.49 to 5.71) and socioeconomic inequality 
was associated with an excess of 1,176 (95% CI 1,036 to 1,306) deaths. The most common causes of 
mortality were unspecified diabetes without complications, and unspecified diabetes mellitus with 
peripheral circulatory complications.  
Between 2004/5 and 2011/12 average mortality fell by 1.57 (95% CI 1.49 to 1.65) deaths per 100,000 
population. Inequality in diabetes mortality as measured by the SII also improved, falling by 2.68 
(95% CI 1.93 to 3.43) resulting in 594 (95% CI 420 to 767) fewer deaths. The main sub-categories of 
mortality reduction were unspecified diabetes without complications which fell from 810 to 320 
deaths, and unspecified diabetes mellitus with peripheral circulatory complications which fell from 
257 to 139 deaths. In contrast, there was a rise in deaths in unspecified diabetes with ketoacidosis 
from 84 to 155 deaths. 
Discussion  
Summary  
This is the first study to examine how the NHS performed in reducing socioeconomic inequalities in 
diabetes outcomes from 2004/5 to 2011/12. During this period, healthcare outcomes improved in all 
social groups for glycaemic control and mortality from diabetes, with larger and faster mortality 
reductions in more deprived social groups. By contrast, both average outcomes and inequalities 
deteriorated in relation to preventable emergency hospitalisation for diabetes-related 
complications.  The fall in diabetes-related mortality is a remarkable achievement, given that 
diabetes prevalence is rising and the targeting of NHS resources often does not promote health 
equity. [16] This finding is consistent with other UK literature and a sign of NHS success with 
improving the quality of healthcare for  diabetes, and more importantly improving the quality of 
healthcare for coronary heart disease and other co-morbidities which contribute to diabetic 
mortality.[17]  Falling mortality may be partly due to the increase in prescribing of statins in diabetes 
patients and more aggressive control of blood pressure, lipid levels and hyperglycaemia, which has 
been shown to reduce morbidity and mortality.[18] By contrast, the growth in emergency 
admissions for diabetes is worrying. It is partly explained by better disease detection by the recent 
addition of the HbA1c test to diagnose diabetes, and increasing prevalence of diabetes rising from 
3.3% in 2004/5 to 5.8% in 2011/12. [19,20,21] There will also be an “unhealthy survivor” effect, 
whereby people with diabetes no longer die prematurely but instead survive long enough to have 
additional admissions for diabetes complications.[22]  
It is also possible that over-use of glucose control medication may be leading to more preventable 
hospitalisation with hypoglycaemic attacks, which have increased by 50% over this time period. Data 
from randomised clinical trials report that intensive glycaemic control immediately increases the risk 
of severe hypoglycaemia 1.5- to 3-fold. [23] Financial incentives in primary care for reaching targets 
for HbA1c have increased from 27 points in 2004/5 to 35 points in 2011/12, the target for one 
indicator has been lowered from HbA1C <10 to HbA1C <9, and an additional indicator has been 
introduced with a target of HbA1c <8.   
Strengths and limitations 
This study used ten years of data including outcome data on virtually all individuals with diabetes in 
England, although the findings are limited to the period of this study. It examined three important 
outcome of diabetes care at different stages of the patient pathway. It also used both absolute and 
relative inequality measures based on the entire socioeconomic gradient of all 32,482 LSOAs in 
England. There were changes in the definition of the indicator of good glycaemic control over time, 
especially for the two years 2009/10 and 2010/11, which complicate the interpretation of trends in 
this indicator.  However, there is no particular reason to think this would impact on the relative 
differences between deprived and affluent neighbourhoods, and so the relative index of inequality 
(RII) remains a fairly robust indicator of inequality trends in glycaemic control.  
 
Comparison with existing literature 
Our findings of an increase in preventable hospitalisations for diabetes complications concur with 
and extend those of Dusheiko and colleagues, who reported an increasing trend in all English GP 
practices from 2004/5 to 2006/7.[24]  Calderón-Larrañaga however, reported a fall in diabetes 
related preventable hospitalisation in the years 2004 to 2009.[25] These differences may be 
explained by the fact that Calderón-Larrañaga adjusted the rate of preventable hospitalisation for 
the prevalence of diabetes, whereas Dusheiko adjusted the rate of preventable hospitalisation by 
population count, age and sex alone as we have done in our analysis. Both approaches have their 
merits, since although diabetes is becoming more common the increase in prevalence may be over-
estimated due to better case finding. [19] Our findings of an increase in the proportion of patients 
meeting targets for HbA1c are similar to findings in Australia, however contrast with findings in the 
USA where no significant change occurred between 2007 and 2012. [26, 27] Our findings of a fall in 
mortality for diabetes are similar to the USA, but contrast with findings in Australia where mortality 
rates have been unchanged from 1997 to 2012. [27, 28] Our findings of increased admissions are 
similar to both Australia and the USA. [27, 29] The increasing admissions for diabetic ketoacidosis in 
type 2 diabetes may be a side effect of newer diabetic drugs. [30] 
 
Implications for research and practice 
The causes of the increase in preventable admissions for hypoglycaemia and ketoacidosis in both 
type I and type II diabetes and increasing inequalities need further research. [31] Reducing 
inequalities in diabetes is likely to require complex interventions to improve the coordination of care 
between multiple providers of care both within and outside the healthcare system. GPs need to be 
aware of socioeconomic inequalities in diabetes care. NICE should review the current target HbA1C 
of 7.0 mmol in light of increasing emergency admissions with hypoglycaemia. GPs should follow NICE 
recommendations in patients who have experienced hypoglycaemia and have an individualised 
HbA1C target for these patients. [2] GPs need to be alert to the risk of DKA in patients taking SGLT2 
inhibitors. [30] 
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Table 1 QOF target for glycated haemoglobin (HbA1c) level [9] 
Indicator name in QOF Years 
Glycated 
haemoglobin 
(HbA1c) 
threshold 
DM6  2004/5; 2005/6  ≤ 7.4%  
DM20  2006/7; 2007/8; 2008/9  
(replaced DM6)  
≤ 7.5%  
DM23  2009/10; 2010/11  
(replaced DM20)  
≤ 7%  
DM26  2011/12 onward  
(replaced DM23)  
≤ 7.5%  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Office for National Statistics classification of preventable diabetes 
admissions (all codes) and amenable deaths  
Type of 
complication  
ICD-10  
Preventable 
admissions codes 
E100, E101, E107, E108, E109,E110, E111, E117, 
E118,E119, E120, E121, E127, E128, E129, E130, E131, 
E137, E138, E139, E140, E141,  
E147, E148, E149, E162,  
 
Amenable mortality 
codes 
 
All ICD-10 codes E10 to E14 
Code type  Definition  
ICD-10 codes  E10: Insulin-dependent diabetes mellitus  
E11: Non-insulin-dependent diabetes mellitus  
E13: Other specified diabetes mellitus  
E14: Unspecified diabetes mellitus  
 
ICD-10 extension  0: With coma  
1: With ketoacidosis  
7: With multiple complications  
8: With unspecified complications  
9: Without complications  
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Socioeconomic healthcare inequalities in England, comparing 2004/2005 with 2011/2012 
Indicator England Mean (95% CI) SII (95% CI) RII (95% CI) Real Inequality Gap (95% CI) 
 
2004 2011 Change 2004 2011 Change 2004 2011 Change 2004 2011 Change 
Diabetes 
Primary Care 
Quality 
 
58.64 
(58.63 to 
58.64) 
62.36 
(62.35 to 
62.36) 
3.72  
(3.72 to 
3.72) 
3.76  
(3.4 to 
4.11) 
3.8 
(3.48 to 
4.11) 
0.04  
(-0.43 to 
0.52) 
0.06  
(0.06 to 
0.07) 
0.06  
(0.06 to 
0.07) 
0  
(-0.01 to 
0) 
1.88  
(1.7 to 
2.05) 
1.9  
(1.74 to 
2.06) 
0.02  
(-0.21 to 
0.25) 
Preventable 
Emergency 
Hospitalisation 
for diabetes 
59.84 
(59.83 to 
59.85) 
71.23 
(71.22 to 
71.25) 
11.4 
(11.38 to 
11.41) 
64.66 
(62.22 to 
67.11) 
84.25 (81.62 
to 86.88) 
19.59 
(16.00 
to 
23.17) 
1.08  
(1.04 to 
1.12) 
1.18  
(1.15 to 
1.22) 
0.1  
(0.05 to 
0.16) 
16199 
(15587 to 
16810) 
22189 
(21498 to 
22881) 
5991 
(5084 to 
6899) 
Amenable 
Mortality from 
diabetes 
3.62 
(3.57 to 
3.67) 
2.04 (1.98 
to 2.11) 
-1.57 
(-1.65 to 
 -1.49) 
5.1  
(4.49 to 
5.71) 
2.42  
(1.98 to 
2.85)  
-2.68 
(-3.43 to  
-1.93) 
1.41 
(1.24 to 
1.58) 
1.18  
(0.97 to 
1.39) 
-0.23  
(-0.5 to 
0.04) 
1176 
(1036 to 
1316) 
582  
(478 to 
687) 
-594  
(-767 to  
-420) 
 
The England means and the SII indices are measured in terms of average primary care quality, preventable hospitalisation per 100,000, and 
amenable mortality per 100,000. The RII indices are the SII indices as a proportion of the England means. The inequality gaps refer to the 
average quality loss attributable to inequality, the total excess hospitalisations attributable to inequality, and the total excess mortality 
attributable to inequality. (RII, relative index of inequality; SII, slope index of inequality.) 
 
 
 
 
 
 
 
 
 
 

Appendix 1: preventable emergency hospitalisation for diabetes  
ICD-10 code 
Q1 (most deprived); % of 
total admissions for ICD-10 
code 
Q5 (most affluent): % of 
total admissions for that 
ICD-10 
Overall numbers of 
admissions for ICD-10 code 
 
2004/5 2011/12 Change 2004/5 2011/12 Change 2004/5 2011/12 Change 
E100 type 1 diabetes with coma 27% 28% 1% 14% 16% 2% 640 313 -327 
E101 type 1 diabetes with ketoacidosis without coma  31% 31% 0% 13% 12% -1% 6271 8841 2570 
E107 type 1 diabetes, multiple complications 34% 0% -34% 21% 42% 21% 53 12 -41 
E108 type 1 diabetes with unspecified complications 28% 21% -7% 14% * * 310 39 -271 
E109 type 1 diabetes without complications 26% 28% 2% 16% 15% -1% 6831 6527 -304 
E110 type 2 diabetes with coma 29% 32% 3% 12% 12% 0% 828 774 -54 
E111 type 2 diabetes with ketoacidosis 32% 32% 0% 11% 12% 1% 1342 2278 936 
E117 type 2 diabetes with multiple complications 14% * * * * * 37 9 -28 
E118 type 2 diabetes with unspecified complications 32% 34% 2% 8% 11% 3% 220 76 -144 
E119 type 2 diabetes without complications 32% 32% 0% 12% 12% 0% 6662 8401 1739 
E121 malnutrition related diabetes with ketoacidosis 0% 0% 0% * 0% * * 0 * 
E129 malnutrition related diabetes no complications * * * * * * * * 0 
E130 other specified diabetes with coma * * * * * * 6 10 * 
E131 other specified diabetes with ketoacidosis * 47% * 0% 12% 12% 13 43 30 
E137 other specified diabetes, multiple complications          0% 0% 0% 0% 0% 0% 0 * * 
E138 other specified diabetes, unspecified complications * 0% * * * * * * * 
E139 other specified diabetes without complications 24% 22% -2% 18% 16% -2% 134 225 91 
E140 unspecified diabetes with coma 26% 24% -2% 12% 32% 20% 91 25 -66 
E141 unspecified diabetes with ketoacidosis 28% 32% 4% 13% 19% 6% 432 209 -223 
E147 unspecified diabetes with multiple complications * * * 0% * * * * 0 
E148 unspecified diabetes with unspecified complications 40% * * 20% * * 30 6 -24 
E149 unspecified diabetes without complications 29% 31% 2% 16% 12% -4% 657 443 -214 
E162 hypoglycaemia, unspecified  30% 30% 0% 12% 13% 1% 7476 11564 4088 
Notes: All numbers are presented as a percentage of the total overall hospitalisations for that ICD-10 code 
            Data derived from patient numbers between 1 and 4 are omitted for confidentiality purposes, and displayed as * 
 
 
 
 
Appendix 2: Amenable deaths from diabetes   
ICD Code Q1 (most deprived); % of total 
deaths for that ICD-10 
Q5 (most affluent): % of total 
deaths for that ICD-10 
Overall numbers of deaths 
for that ICD-`10 
2004/5 2011/12 Change 2004/5 2011/12 Change 2004/5 2011/12 Change 
E100 type 1 diabetes with coma 0% * * * 0% * 6 * * 
E101 type 1 diabetes with ketoacidosis without coma 56% 40% -16% 13% * * 16 30 14 
E102 type 1 diabetes with renal complications * * * * 0% * 13 11 -2 
E104 type 1 diabetes with neurological complications * 0% * 0% 0% 0% * * * 
E105 type 1 diabetes with peripheral circulatory complications 33% * * 0% * * 18 18 0 
E106 type 1 diabetes with other specified complications 0% 0% 0% 0% * * 0 * * 
E107 type 1 diabetes, multiple complications * * * * * * * 6 * 
E109 type 1 diabetes without complications 31% 30% -1% 15% 17% 2% 102 64 -38 
E110 type 2 diabetes with coma 0% * * 0% 0% 0% * 5 * 
E111 type 2 diabetes with ketoacidosis * 60% * 0% 0% 0% * 10 * 
E112 type 2 diabetes with renal complications 42% 28% -14% 0% * * 19 39 20 
E114 type 2 diabetes with neurological complications  * * * 0% * * * 6 * 
E115 type 2 diabetes, peripheral circulatory complications 25% 34% 9% * 13% * 61 83 22 
E116 type 2 diabetes with other specified complications 0% 0% 0% 0% * * 0 * * 
E117 type 2 diabetes with multiple complications 36% 29% -7% 0% 0% 0% 14 17 3 
E119 type 2 diabetes without complications 32% 23% -9% 10% 12% 2% 188 146 -42 
E140 unspecified diabetes with coma 37% * * 0% 0% 0% 27 15 -12 
E141 unspecified diabetes with ketoacidosis 36% 42% 6% 0% 0% 0% 84 155 71 
E142 unspecified diabetes, renal complications 28% 21% -7% 13% 14% 1% 92 91 -1 
E144 unspecified diabetes, neurological complications * 0% * * 0% * 6 * * 
E145 unspecified diabetes, peripheral circulatory comps. 36% 29% -7% 11% 13% 2% 257 139 -118 
E146 unspecified diabetes, other specified complications 0% 0% 0% 0% 0% 0% * 0 * 
E147 unspecified diabetes with multiple complications 24% * * 15% * * 46 32 -14 
E149 unspecified diabetes without complications 32% 39% 7% 12% 10% -2% 810 320 -490 
Notes: All numbers are presented as a percentage of the total overall deaths for that ICD-10 code 
            Data derived from patient numbers between 1 and 4 are omitted for confidentiality purposes, and displayed as * 
 
 
 
